Item specifics

New with box: A brand-new, unused, unworn and undamaged item in its original packaging (such as the original box ... Read moreabout the condition
EAN: 5054167577764
Dimensions: L 11.89 x W 6.89 x H 4.61 inches Brand: Inov-8
Label: inov-8 MPN: 000567-GYPK-M-01
NumberOfItems: 1 Binding: Apparel
PartNumber: 000567-GYPK-M-01-20-7.5 B US Color: Grey/Pink
ProductGroup: Shoes Department: womens
UPC: Not Applicable Weight: 1.45 lbs
ISBN: Not Applicable
Inov-8 Women's All Train 215 W Cross Trainer, Grey Pink, 7.5 B US

Nationally Ranked Specialties

Equi-Theme Luxury Padded Double Zip Tall Long Equestrian Horse Riding Boot Bag

Building Update

Building Elevated View

University of Iowa Stead Family Children’s Hospital is designed as a healing environment that improves the health and well-being of children and their families. Plans include expanding existing programs and developing new services on-site and throughout Iowa to meet the current and future needs of Iowa’s children.

Schnürstiefelette Monaco Glattleder, black Gr. 38



1X(Fishing Bite Alarm Set 4 Alarms + 1 Receiver Wireless Digital Fishing Bi P9E3

University of Iowa Stead Family Children’s Hospital joins a group of more than 30 sites across the country committed to using research and education to help prevent injury to children.

Daiwa Morethan 12 Braid 0,10mm 7,3kg 135m Lime Green Geflochtene Schnur

Join us on Friday, July 12 at University of Iowa Health Care - Iowa River Landing for a bike safety event geared to the whole family.

Edward Bell receives mentor award from Pediatric Academic Societies

Women's NIKE POWER Legend Training Tights Small. 874733-043

Edward Bell, MD, a neonatologist at University of Iowa Stead Family Children’s Hospital, has been awarded the Maureen Andrew Mentor Award from the Society of Pediatric Research, following his 40 years in pediatric medicine.

UI study suggests new approach to treating kids with relapsed cancer

MARKER Women's 8 One Piece Snowsuit Ski Weatherproof Insulated Hooded Excellent

UI researchers led by Miles Pufall, PhD, have identified a new target that may help improve treatment for children with relapsed B-cell acute lymphoblastic leukemia (B-ALL), the most common type of childhood cancer.